Guardian Pharmacy Services, Inc. (NYSE:GRDN) Shares Sold by Maven Securities LTD

Maven Securities LTD cut its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 39.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 109,723 shares of the company's stock after selling 70,820 shares during the period. Maven Securities LTD owned about 0.17% of Guardian Pharmacy Services worth $2,223,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also bought and sold shares of the company. Envestnet Asset Management Inc. boosted its position in Guardian Pharmacy Services by 4.9% during the 4th quarter. Envestnet Asset Management Inc. now owns 12,010 shares of the company's stock valued at $243,000 after acquiring an additional 564 shares in the last quarter. LPL Financial LLC lifted its stake in shares of Guardian Pharmacy Services by 4.8% during the 4th quarter. LPL Financial LLC now owns 17,679 shares of the company's stock worth $358,000 after purchasing an additional 807 shares during the last quarter. Lazard Asset Management LLC boosted its position in Guardian Pharmacy Services by 0.5% during the fourth quarter. Lazard Asset Management LLC now owns 190,797 shares of the company's stock valued at $3,865,000 after purchasing an additional 860 shares in the last quarter. R Squared Ltd purchased a new position in Guardian Pharmacy Services in the fourth quarter valued at about $30,000. Finally, Investment Research & Advisory Group Inc. purchased a new position in Guardian Pharmacy Services in the fourth quarter valued at about $34,000.

Guardian Pharmacy Services Stock Performance

Shares of GRDN stock traded down $0.30 during trading hours on Friday, reaching $24.62. 88,787 shares of the company's stock were exchanged, compared to its average volume of 146,109. The stock's 50 day moving average is $22.74 and its 200-day moving average is $21.82. Guardian Pharmacy Services, Inc. has a fifty-two week low of $14.16 and a fifty-two week high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported $0.21 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.01). The company had revenue of $329.31 million during the quarter, compared to analysts' expectations of $321.21 million. Analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, Truist Financial increased their price target on shares of Guardian Pharmacy Services from $24.00 to $25.00 and gave the company a "buy" rating in a research report on Friday, April 11th.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.